Replies to post #534714 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

Thanks for asking about the statistical analysis plan.

I would not be concerned about the SAP because statistical analysis was part of the peer review. Additionally, both Liau and Ashkan are clinical trial experts.

Dr. Linda Liau is a world-renowned neuro-oncologist, surgeon, and educator at UCLA where she is also the chair of the department of neurosurgery. Dr. Liau has authored over 170 peer-reviewed articles, several book chapters, and a textbook entitled Brain Tumor Immunotherapy. She is on the editorial boards of several scientific/medical journals and was the Editor-in-Chief of the Journal of Neuro-Oncology (2007–2017).



https://www.uclahealth.org/providers/linda-liau

https://doi.org/10.3171/2020.12.FOCUS20954

https://nwbio.com/wp-content/uploads/jamaoncology_liau_2022_oi_220066_1668698380.80695.pdf

Dr. Ashkan was the chief investigator of the murcidencel trial for patients in Europe. At King’s College in London, Ashkan is the lead clinician for neuro-oncology and the chair of the King’s Neurosciences Clinical Trial Unit. He is a world-renowned cancer trial expert. A few years ago, Professor Ashkan was named the UK Clinician of the Year by The Brain Tumour Charity. Additionally, Ashkan serves as an advisor to the U.K. government.

https://www.kcl.ac.uk/people/keyoumars-ashkan

https://virtualtrials.org/dcvax.cfm

$nwbo pic.twitter.com/8hD4wfaHF1

— Blake (@MC17595091) November 15, 2022

[Dr Bala]

Go and find the answer yourself. It is not my concern.